Litigants Weigh Appeal To Australian Court Ruling Over Myriad Genetics’ Rights For BRCA1 Gene
This article was originally published in PharmAsia News
Executive Summary
Australian Federal Court rules in Myriad Genetics favor that BRCA1 gene can be patented, but whether the ruling will be upheld is another story.